Recursion
We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt Lake City.
Our mission is to Decode Biology to Radically Improve Lives. Through technologies like automation, new biological tools, and artificial intelligence, we believe we can generate intelligent maps of biology and navigate those maps to more effective medicines.
Historically, it has taken over ten years and an average capitalized R&D cost of approximately $2 billion per approved medicine to move a drug discovery project from early discovery to an approved therapeutic. This failure rate disappoints patients who are waiting for therapy and incurs huge costs that drive up drug prices.
Our mindset is guided by an unwavering drive to challenge and disrupt the status quo. We diligently guard against complacency, conservatism, risk aversion, and contentment with the familiar. We are not here to make a few medicines. We are here to reimagine how medicines are made.
The recursion mindset is the deep belief and commitment to industrializing drug discovery through automation, algorithms, and data to deliver on our mission. This is made manifest through our founding principles and is supported by our culture and values.
